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Summary Cytogenetic analysis was carried out on peripheral blood cultures from seven patients with acute
promyelocytic leukaemia (APL-M3). A reciprocal 15;17 chromosome translocation, t(lSq+; 17q-), was found
in all cases, and the breakpoints estimated to be 15q22 and 17ql2-21. In addition to the t(15q+;17q-),
trisomy 10 was found in 50% of cells analysed in one case. These results suggest that the 15;17 chromosome
translocation may be observed in most cases of APL where the leukaemic cells are cultured before cytogenetic
analysis is performed. The use ofconditioned media in the culture of leukaemic cells is also described.
Acute promyelocytic leukaemia (FAB-classification
M3) is characterised by marked haemorrhagic
episodes, disseminated intravascular coagulation,
and infiltration of the bone marrow with abnormal
promyelocytes containing heavy azurophilic
granulation. Some promyelocytes contain multiple
Auer rods (Bennett et al., 1976). A morphological
variant of APL has been recognised with the same
clinical features as APL (called microgranular APL
or M3-variant) in which the leukaemic cells have
abnormal bilobed, multilobed or reniform nuclei,
and are either devoid of granules or have a few fine
azurophilic granules (Bennett et al., 1980; McKenna
et al., 1982).
An abnormal chromosome 17 was first
recognised in the leukaemic cells of APL patients
by Golomb et al. (1976), and subsequently shown
to result from a balanced 15q+;17q- chromosome
translocation (Rowley et al., 1977a; Golomb et al.,
1979). This translocation has since been identified
in both the the typical and variant forms of APL,
with the data collected at the Second International
Workshop on Chromosomes on Leukemia, 1979
(1980) suggesting a geographic variation in the
incidence 15q+;17q- chromosome translocation in
APL. More recently, however, by analysing whether
cells have been cultured prior to chromosome
preparation, it has been shown that the apparently
uneven geographic distribution can probably be
accounted for by methodological differences in
chromosome preparation (Berger et al., 1980;
Fourth International Workshop on Chromosomes
in Leukemia 1982, 1984).
Four cases of APL from England were
considered at the Fourth International Workshop
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on Chromosomes in Leukemia, 1982 (1984), and
none of these showed the 15q+;17q- chromosome
translocation. There has only been one report of a
case of APL in England showing this translocation
(Sheer et al., 1982). Cytogenetic findings are now
presented on a further seven patients with this
disease. In addition, the use of conditioned media
for obtaining chromosome preparations from
frozen leukaemic cells is described.
Materials and methods
Patients were diagnosed as having APL (M3) on
the basis of FAB criteria. Clinical details ofpatients
at the time of diagnosis are summarised in Table I.
None of the patients had received therapy prior to
peripheral blood samples being taken. Peripheral
blood leukocytes from three patients had been
frozen in liquid nitrogen for 2-3 years prior to
cytogenetic analysis. Samples were cultured for 24
to 96h in RPMI 1640, 20% foetal calf serum,
0.03% glutamine and 20uml1 heparin.
Conditioned medium from 7-day cultures of PHA-
stimulated peripheral blood lymphocytes (PHA-
LCM) and of the human bladder carcinoma cell
line 5637 (5637-CM), which has been shown to
secrete growth factors for myeloid cells (Myers et
al., 1984) was added to most cultures to a final
concentration of 10% (Table II). Ethidium bromide
was added to cultures from all patients except JD
and IL, together with colcemid for 1-1.5h prior to
chromosome harvest, to a final concentration of
lOgmlP1 (Ikeuchi & Sasaki, 1979). Chromosomes
were prepared according to standard procedures
and chromosome abnormalities identified by G-
banding (Seabright, 1971) and Q-banding
(Caspersson et al., 1971). Ten to twenty meta-
phase spreads were analyzed in each case.
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Table I Haematological and clinical data on patients with acute promyelocytic leukaemia
Hb WBC Blasts Promyelocytes Platelets Auer Complete Survival
Patient Age (gd1-1) (xJO91-1) (xJO91-1) (x1091-1) (x1091-1) rods remission (mo.)
IL 72 9.0 45.3 2.7 41.7 27 +ve no <1
JD 26 9.4 94.7 90.0 33 -ve no <1
EB 45 6.1 78.4 73.7 23 +ve no <1
HC 27 10.4 10.3 0.2 7.0 26 -ve yes >10
GB 54 7.0 6.5 5.4 48 +ve yes >9
PN 37 7.6 0.8 0.1 19 +ve yes >6
VC 39 5.3 0.7 0.5 38 +ve no 9
Results
A typical 1Sq+;17q- chromosome translocation
was found in every case (Table II). The chromo-
some breakpoints in one patient (J.D.) were
localised to 15q22 and 17ql2-21 by genetic analysis
of an interspecific somatic cell hybrid containing
the 15q+ translocation chromosome (Sheer et al.,
1983). No other clonal chromosome abnormalities
were found, other than trisomy 10 which was
present in 50% of metaphases analysed in one
patient. Figure 1 shows a representative karyotype
from one patient.
Cytogenetic analysis was attempted on frozen
blood samples from a total of 6 patients with APL.
No dividing cells were obtained from 3 of these
samples where no conditioned medium was added
(data from three successful cultures shown in Table
II). As we were also unable to obtain dividing cells
Figure 1 Q-banded karyotype of APL patient G.B.
showing 1 Sq+;17q
- chromosome translocation and
trisomy 10.
from frozen sample EB without conditioned
medium, EB was cultured in medium containing
PHA-LCM. Only 3 analysable metaphases were
obtained from this culture and all had normal
chromosomes 15 and 17. Therefore EB was
cultured in medium containing 5637-CM, resulting
in a substantial increase in the number of dividing
cells. A 1Sq+;17q- chromosome translocation was
found in all cells analysed from this culture of EB.
Good chromosome preparations were obtained
from frozen samples JD and IL with the addition
of PHA-LCM to the cultures.
Discussion
We have thus found a 15q+;17q- chromosome
translocation in each of our seven patients with
APL. Apart from one previous case described by
us, the translocation has not been reported in
England. The question of whether differences in
chromosome preparation contributed to the
apparently uneven geographic distribution of the
translocation noted at the Second International
Workshop on Chromosomes in Leukemia, 1979
(1980), was investigated at the Fourth International
Workshop on Chromosomes in Leukemia, 1982
(1984). The percentage of bone marrow samples
which had clonal karyotypically abnormal cells rose
from 44% in direct preparations, to 66% in 24-48h
cultures, to 80% in cultures exposed to metho-
trexate. In addition, the 15q+;17q- chromosome
translocation was found in 20% more cases (70%
total) than at the Second Workshop. These results,
and those of others (e.g. Yunis, 1982) show that
high resolution banding techniques allow better
visualisation of the rearranged chromosomes, and
that a period of in vitro culture substantially
increases the likelihood of detecting a karyo-
typically abnormal clone. Berger et al. (1980) have
suggested that the dividing cells in direct
preparations from APL may be erythroblasts withCHROMOSOMES IN APL 57
Table II Cytogenetic data on patients with acute promyelocytic leukaemia
No. of
Blood Hours Conditioned Yield metaphases
Patient sample cultured medium metaphases examined Karyotypes
IL frozen 48 few -
48 PHA-LCM good 20 46,XX,t(15;17)
JD frozen 48 few
48 PHA-LCM good 20 46,XY,t(15;17)
EB frozen 48 none -
48 PHA-LCM few 3 46,XX
48 5637-CM good 12 46,XX,t(15;17)
HC fresh 24 5637-CM few -
48 5637-CM fair
96 5637-CM good 12 46,XX,t(15;17)
GB fresh 48 5637-CM good 16 46,XX,t(15;17)[50%]/
47,XX,t(15;17),+ 10
PN fresh 48 PHA-LCM few
48 5637-CM good 20 46,XY,t(15;17)
VC fresh 24 PHA-LCM none
24 5637-CM few
48 PHA-LCM fair
48 5637-CM good 18 46,XX,t(15;17)[89%]/
46,XX
normal karyotypes, whereas the major dividing
population after 24-48h of culture is made up of
leukaemic cells.
Chromosome preparations were made from
frozen blood samples from three patients with APL
by culturing the cells in medium containing either
PHA-LCM or 5637-CM. No dividing cells were
obtained from one of these samples (EB) or from
frozen samples from three different APL patients
(data not shown) where no conditioned medium
was added to the cultures. A reasonable number of
dividing cells were obtained from cultures of frozen
samples JD and IL with PHA-LCM. In contrast,
only a few dividing cells were found in the third
frozen sample, EB, with PHA-LCM after 24h in
culture and these all showed a normal karyotype. It is
possible that these were normal cells stimulated to
divide by the PHA in the conditioned medium.
When the sample from EB was cultured in medium
containing 5637-CM, however, a large number of
dividing cells were found, showing the 15q+;17q-
translocation. We were also able to obtain good
chromosome preparations from all our fresh
samples with the addition of 5637-CM to the
cultures. Finally, the use of ethidium bromide in
later chromosome preparations allowed us to
obtain elongated chromosomes, thus facilitating the
identification of the translocation in these
preparations.
The exact locations of the chromosome break-
points in the 15q+;17q- translocation have been
difficult to determine cytologically and have been
sited at different positions by different investi-
gators, e.g. 15q22 and 17q21 (Rowley et al., 1977b)
and 15q25 and 17q22 (Second International Work-
shop on Chromosomes in Leukemia, 1980). More
recently, however, the analysis of elongated
chromosomes with R-. Q- and G-banding has
resulted in general agreement over the siting of the
breakpoints at 15q22, possibly 15q2200, and 17q12-
21 (Fourth International Workshop on Chromo-
somes in Leukemia, 1984; Hagemeijer et al., 1982;
Larson et al., 1984). Analysis of interspecific
somatic cell hybrids derived from one APL patient
(JD) has confirmed the localisation of the trans-
location breakpoints to 15q22 and 17ql2-21 (Sheer
et al., 1983).
In addition to the 15;17 chromosome trans-
location, trisomy 10 was found in one patient
(G.B.) Trisomy 10 is not specifically associated with
APL, although it has been previously reported in
one case (Brodeur et al., 1983). Trisomy 10 might
be a secondary chromosome aberration in the
patient G.B., since it was only observed in 50% of
cells analysed.
Our results are in agreement with those of
Larson et al. (1984) who found a 15q+;17q-
translocation in every one of their 27 patients with
APL studied in Chicago. The translocation has not
been reported in any other type of malignancy
(Mitelman, 1984), other than in a promyelocytic
form of chronic myeloid leukaemia blast crisis
(Berger et al., 1983). The oncogene c-erbAl has
been localised immediately proximal to the APL58 D. SHEER et al.
breakpoint on chromosome 17 (Sheer et al., 1985).
The specificity and incidence of the translocation
suggest the presence of a gene which plays a role in
myeloid differentiation at the promyelocyte stage,
at one of the translocation breakpoints on chromo-
some 15 or 17. The juxtaposition of this gene with
sequences from the other translocation chromo-
some, possibly the oncogene c-erbAl, could play a
crucial role in the development of this malignancy.
We wish to thank Dr T.R. Mitchell for allowing us to
include haematological and clinical data on patient V.C.,
Dr J. Fogh for providing the cell line 5637, and Keith
Adams for kind assistance.
Note added in proof:
The t(15; 17) translocation has recently been
reported in patients with APL at the Royal
Marsden Hospital, London. See Swansbury, G.J.,
Feary, S.W., Clink, H.M. & Lawler, S.D. (1985).
Leukemia Research, 9, 271.
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